Cell therapy has been regarded as strategically important sector in biomedicine by Chinese government during recent years. As academic researches and clinical trials increase rapidly,  regulation and commercialization have become top priority for the healthy development of the industry.

As leading online & offline platform in biomedicine area, Bioon has been organizing Cell Therapy Conference for 10 consecutive years and is widely recognized by Chinese professionals for the contribution. In 2020, Bioon will make endeavors to bring more international professionals to join the annual conference, sharing knowledge and insights from different perspectives.

Attendee profile: academia, clinicians, pharmaceutical and biotechnology companies, regulators, universities, investors and other professionals

Main topics: stem cell & regenerative medicine, CAR-T  cell therapy, cancer immunotherapy, gene therapy, intelligent manufacturing, IND, policies & regulations, investment, and more